two new injectable diabetes drugs, Byetta (exenatide) and Symlin (pramlintide)

June 2005

There's a lot of interest in two new injectable diabetes drugs, Byetta (exenatide) and Symlin (pramlintide).

These drugs are the first of their kind. They both mimic hormones that help regulate blood glucose.

Byetta is an incretin mimetic. It's the one that's based on a protein derived from Gila monster saliva.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote